KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Shares Outstanding (2016 - 2025)

Boston Scientific's Shares Outstanding history spans 7 years, with the latest figure at $10.1 million for Q1 2023.

  • For Q1 2023, Shares Outstanding fell 99.41% year-over-year to $10.1 million; the TTM value through Mar 2023 reached $10.1 million, down 99.41%, while the annual FY2022 figure was $10.1 million, 0.0% changed from the prior year.
  • Shares Outstanding for Q1 2023 was $10.1 million at Boston Scientific, roughly flat from $10.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $1.7 billion in Q3 2020 and bottomed at $10.1 million in Q2 2020.
  • The 5-year median for Shares Outstanding is $10.1 million (2020), against an average of $478.7 million.
  • The largest annual shift saw Shares Outstanding soared 16645.41% in 2021 before it crashed 99.41% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $1.6 billion in 2019, then crashed by 99.39% to $10.1 million in 2020, then changed by 0.0% to $10.1 million in 2021, then changed by 0.0% to $10.1 million in 2022, then changed by 0.0% to $10.1 million in 2023.
  • Per Business Quant, the three most recent readings for BSX's Shares Outstanding are $10.1 million (Q1 2023), $10.1 million (Q4 2022), and $10.1 million (Q3 2022).